Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

328
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
328
Drug Therapy01:28

Drug Therapy

337
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
337
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Dementia01:30

Dementia

619
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
619
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

288
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
288

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

STELLA-FTD: Examination of a Behavior Change Intervention for Frontotemporal Dementia Family Care Partners.

Alzheimer's & dementia. Behavior & socioeconomics of aging·2026
Same author

Biomarkers.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Dementia diagnosis in primary care: testing an educational program in Oregon.

Gerontology & geriatrics education·2025
Same author

Dementia Care Research and Psychosocial Factors.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Dementia Care Research and Psychosocial Factors.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Dementia Care Research and Psychosocial Factors.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

Related Experiment Video

Updated: Mar 3, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

8.2K

Medication Management for People with Dementia.

Allison Lindauer1, Kathryn Sexson, Theresa A Harvath

  • 1Allison Lindauer is an assistant professor at Oregon Health and Science University, Portland. Kathryn Sexson is a family NP at Denali Family Healthcare and an assistant professor in the School of Nursing, University of Alaska, Anchorage. Theresa A. Harvath is the associate dean for academics in the Betty Irene Moore School of Nursing, University of California, Davis, in Sacramento. The authors would like to acknowledge Susan C. Reinhard and Heather M. Young, leaders of the No Longer Home Alone video project, and the contributions of Carol Levine, who conducted focus groups with family caregivers regarding the challenges of medication management. Contact author: Allison Lindauer, lindauer@ohsu.edu. The authors have disclosed no potential conflicts of interest, financial or otherwise.

The American Journal of Nursing
|April 29, 2017
PubMed
Summary

Family caregivers often lack essential information for managing complex medical needs. This series, including this article and video, equips nurses to better support caregivers with medication management strategies.

More Related Videos

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

34.0K
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

1.0K

Related Experiment Videos

Last Updated: Mar 3, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

8.2K
The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

34.0K
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

1.0K

Area of Science:

  • Nursing
  • Caregiver Support
  • Health Information Dissemination

Background:

  • Family caregivers frequently encounter challenges in managing complex patient care regimens.
  • A significant gap exists in providing adequate information to family caregivers.
  • This article is part of a series focused on empowering family caregivers.

Purpose of the Study:

  • To provide nurses with tools and principles to educate family caregivers on medication management.
  • To address the information deficit faced by family caregivers.
  • To support the 'No Longer Home Alone' initiative by AARP Public Policy Institute.

Main Methods:

  • Focus groups were conducted as part of the AARP Public Policy Institute's 'No Longer Home Alone' video project.
  • Evidence was gathered on the information needs of family caregivers.
  • This article presents principles for nurses to reinforce with caregivers, accompanied by a video resource.

Main Results:

  • Focus group results confirmed that family caregivers are not receiving sufficient information.
  • The need for accessible and practical medication management guidance for caregivers is evident.
  • The series aims to bridge this information gap through educational content for nurses.

Conclusions:

  • Nurses play a crucial role in equipping family caregivers with necessary medication management skills.
  • Improved information dissemination can enhance the ability of family caregivers to manage complex care.
  • This educational series provides a valuable resource for both nurses and family caregivers.